Biotechnology
The Biotechnology industry has a total of 601 stocks, with a combined market cap of $1.13 trillion and total revenue of $105.3 billion.
Market Cap
1.13T
Revenue
105.3B
Profits
-41.51B
PE Ratio
n/a
Profit Margin
-39.42%
Dividend Yield
0.05%
601 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.57B | 4.82% | 1,214,352 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.15B | 1.15% | 426,998 | 14.25B |
| 3 | ARGX | argenx SE | 49.82B | 0.55% | 241,907 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 47.90B | 1.98% | 1,030,893 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 38.13B | 3.08% | 189,024 | 4.97B |
| 6 | INSM | Insmed Incorporated | 33.51B | -3.90% | 1,832,903 | 447.02M |
| 7 | BNTX | BioNTech SE | 29.35B | 10.82% | 1,476,494 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.89B | 1.43% | 3,447,409 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.72B | 1.14% | 2,385,874 | - |
| 10 | INCY | Incyte Corporation | 20.61B | 2.32% | 903,777 | 4.81B |
| 11 | GMAB | Genmab A/S | 20.15B | 5.51% | 1,399,349 | 3.85B |
| 12 | MRNA | Moderna, Inc. | 19.08B | 13.56% | 15,687,759 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 16.00B | 0.09% | 3,185,675 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.07B | 1.32% | 1,272,737 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.23B | -0.06% | 352,676 | 758.59M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.83B | 3.61% | 2,456,710 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.83B | 2.15% | 2,465,576 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 12.14B | 2.99% | 1,068,309 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.37B | -0.83% | 126,372 | 740.64M |
| 20 | TECH | Bio-Techne Corporation | 11.06B | 2.08% | 1,584,584 | 1.22B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.94B | 0.17% | 1,388,968 | 20.87M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.86B | 0.37% | 991,687 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.30B | 0.94% | 293,277 | 4.16B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.43B | 1.39% | 810,094 | 561.26M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.34B | 0.60% | 678,585 | 6.23M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.28B | 3.45% | 1,025,135 | 829.45M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.62B | -4.13% | 389,882 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.44B | 1.96% | 576,532 | 1.24B |
| 29 | NUVL | Nuvalent, Inc. | 8.38B | 1.88% | 267,904 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 8.26B | 3.69% | 118,594 | 373.16M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.74B | -0.75% | 1,187,345 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.15B | -3.50% | 1,293,263 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.98B | 1.90% | 300,162 | 174.33M |
| 34 | IBRX | ImmunityBio, Inc. | 6.69B | 4.78% | 82,645,781 | 82.56M |
| 35 | PCVX | Vaxcyte, Inc. | 6.48B | 4.12% | 685,194 | - |
| 36 | GPCR | Structure Therapeutics Inc. | 6.47B | 2.81% | 1,222,101 | - |
| 37 | COGT | Cogent Biosciences, Inc. | 6.07B | 0.01% | 2,010,819 | - |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.06B | 3.32% | 677,734 | 1.78B |
| 39 | BLTE | Belite Bio, Inc | 5.93B | -1.26% | 76,635 | - |
| 40 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.72B | 0.13% | 522,071 | 1.54M |
| 41 | KYMR | Kymera Therapeutics, Inc. | 5.59B | 2.47% | 388,790 | 43.74M |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.48B | -0.94% | 441,119 | - |
| 43 | IMVT | Immunovant, Inc. | 5.32B | 0.34% | 791,693 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.22B | 0.02% | 800,580 | 209.22M |
| 45 | CRSP | CRISPR Therapeutics AG | 5.16B | 3.00% | 1,118,884 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.96B | 1.63% | 357,787 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.80B | 1.16% | 1,611,943 | 471.79M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.66B | 2.09% | 794,693 | - |
| 49 | CGON | CG Oncology, Inc. | 4.59B | 4.06% | 2,298,486 | 2.17M |
| 50 | TGTX | TG Therapeutics, Inc. | 4.57B | 0.97% | 894,004 | 531.90M |
| 51 | ACAD | ACADIA Pharmaceuticals Inc. | 4.53B | 1.94% | 850,790 | 1.05B |
| 52 | FOLD | Amicus Therapeutics, Inc. | 4.43B | 0.07% | 2,710,761 | 598.70M |
| 53 | ADMA | ADMA Biologics, Inc. | 4.11B | -1.82% | 1,115,846 | 488.56M |
| 54 | ACLX | Arcellx, Inc. | 4.02B | -3.69% | 788,534 | 35.90M |
| 55 | TERN | Terns Pharmaceuticals, Inc. | 4.01B | 0.81% | 958,139 | - |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.97B | 2.73% | 111,754 | 251.23M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.84B | 3.51% | 891,590 | 741.17M |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.83B | 4.24% | 632,832 | 35.24M |
| 59 | LEGN | Legend Biotech Corporation | 3.74B | -13.54% | 6,638,547 | 909.05M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.73B | -1.52% | 1,939,473 | - |
| 61 | LQDA | Liquidia Corporation | 3.48B | 1.65% | 1,305,583 | 69.22M |
| 62 | CNTA | Centessa Pharmaceuticals plc | 3.40B | 1.68% | 5,978,907 | 15.00M |
| 63 | ALMS | Alumis Inc. | 3.35B | 3.03% | 1,348,300 | 22.12M |
| 64 | VERA | Vera Therapeutics, Inc. | 3.21B | 0.74% | 777,498 | - |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.19B | 0.81% | 1,264,893 | 317.93M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.18B | -0.94% | 1,012,125 | 7.50M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.14B | 0.20% | 470,289 | 214.83M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.12B | 2.61% | 1,114,262 | - |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.10B | -0.46% | 566,633 | 70.79M |
| 70 | BEAM | Beam Therapeutics Inc. | 3.08B | 0.69% | 1,456,103 | 55.70M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.98B | -1.03% | 295,491 | 366.10M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.95B | 2.69% | 535,635 | 578.20M |
| 73 | ERAS | Erasca, Inc. | 2.88B | 3.36% | 7,051,648 | - |
| 74 | DNLI | Denali Therapeutics Inc. | 2.88B | 5.08% | 1,173,960 | - |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.86B | 4.76% | 805,765 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.83B | 1.22% | 262,218 | - |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.81B | 3.60% | 502,754 | 240.00M |
| 78 | IMNM | Immunome, Inc. | 2.72B | 3.27% | 1,319,489 | 9.68M |
| 79 | ADPT | Adaptive Biotechnologies Corporation | 2.69B | -1.51% | 1,035,943 | 252.75M |
| 80 | APLS | Apellis Pharmaceuticals, Inc. | 2.67B | 3.13% | 2,255,670 | 1.02B |
| 81 | SYRE | Spyre Therapeutics, Inc. | 2.62B | 0.15% | 356,118 | - |
| 82 | WVE | Wave Life Sciences Ltd. | 2.53B | -0.14% | 1,799,517 | 109.23M |
| 83 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | -1.75% | 591,782 | - |
| 84 | TVTX | Travere Therapeutics, Inc. | 2.48B | -0.86% | 1,062,152 | 435.83M |
| 85 | TLX | Telix Pharmaceuticals Limited | 2.43B | -5.82% | 246,588 | 664.23M |
| 86 | OCUL | Ocular Therapeutix, Inc. | 2.40B | -1.75% | 3,166,999 | 55.78M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.37B | 3.64% | 23,666,721 | 43.69M |
| 88 | AAPG | Ascentage Pharma Group International | 2.36B | -0.04% | 1,535 | 54.52M |
| 89 | SLNO | Soleno Therapeutics, Inc. | 2.30B | -2.01% | 585,966 | 98.68M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | 2.04% | 1,480,098 | 2.41B |
| 91 | MESO | Mesoblast Limited | 2.18B | 2.97% | 211,638 | 17.20M |
| 92 | GLPG | Galapagos NV | 2.18B | -0.33% | 137,088 | 336.64M |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.17B | -0.22% | 1,791,719 | 630.60M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 2.11B | 1.81% | 299,887 | 825.94M |
| 95 | ZLAB | Zai Lab Limited | 2.09B | -0.79% | 430,511 | 441.63M |
| 96 | MAZE | Maze Therapeutics, Inc. | 2.08B | -2.37% | 298,640 | 2.50M |
| 97 | NUVB | Nuvation Bio Inc. | 2.08B | 0.92% | 4,315,411 | 26.75M |
| 98 | OLMA | Olema Pharmaceuticals, Inc. | 2.07B | -1.50% | 470,444 | - |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 2.02B | 0.90% | 483,427 | 3.08M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.94B | -0.68% | 414,497 | 265.81M |
| 101 | ARDX | Ardelyx, Inc. | 1.92B | 1.93% | 6,574,721 | 398.23M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.91B | 3.07% | 677,510 | 83.69M |
| 103 | GLUE | Monte Rosa Therapeutics, Inc. | 1.90B | -1.60% | 512,482 | 181.54M |
| 104 | VCEL | Vericel Corporation | 1.90B | 3.66% | 223,257 | 258.72M |
| 105 | SION | Sionna Therapeutics, Inc. | 1.82B | 2.01% | 133,843 | - |
| 106 | MBX | MBX Biosciences, Inc. | 1.81B | -6.31% | 530,321 | - |
| 107 | ZYME | Zymeworks Inc. | 1.79B | 0.89% | 350,424 | 134.48M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 1.24% | 587,528 | 111.30M |
| 109 | IMCR | Immunocore Holdings plc | 1.78B | 5.49% | 875,601 | 379.59M |
| 110 | MNKD | MannKind Corporation | 1.74B | 3.28% | 2,861,135 | 313.79M |
| 111 | PHVS | Pharvaris N.V. | 1.73B | 1.68% | 67,557 | - |
| 112 | BHVN | Biohaven Ltd. | 1.73B | 2.84% | 2,410,929 | - |
| 113 | CLDX | Celldex Therapeutics, Inc. | 1.73B | 3.42% | 205,661 | 2.60M |
| 114 | UPB | Upstream Bio, Inc. | 1.70B | 1.61% | 308,372 | 2.80M |
| 115 | STOK | Stoke Therapeutics, Inc. | 1.69B | 3.10% | 331,935 | 205.63M |
| 116 | DFTX | Definium Therapeutics, Inc. | 1.68B | 1.49% | 2,244,066 | - |
| 117 | TNGX | Tango Therapeutics, Inc. | 1.68B | -0.56% | 2,312,801 | 66.50M |
| 118 | ORKA | Oruka Therapeutics, Inc. | 1.67B | 3.79% | 443,416 | - |
| 119 | RAPT | RAPT Therapeutics, Inc. | 1.67B | 0.04% | 1,536,227 | - |
| 120 | KOD | Kodiak Sciences Inc. | 1.66B | 0.49% | 343,700 | - |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.61B | 0.22% | 736,965 | - |
| 122 | CRVS | Corvus Pharmaceuticals, Inc. | 1.61B | 0.42% | 11,785,640 | - |
| 123 | NVAX | Novavax, Inc. | 1.60B | 20.06% | 13,666,919 | 1.06B |
| 124 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 7.56% | 7,420,380 | 57.53M |
| 125 | FTRE | Fortrea Holdings Inc. | 1.58B | 8.09% | 469,168 | 2.76B |
| 126 | AGIO | Agios Pharmaceuticals, Inc. | 1.57B | 1.22% | 713,822 | 44.79M |
| 127 | TYRA | Tyra Biosciences, Inc. | 1.57B | -0.17% | 407,128 | - |
| 128 | PGEN | Precigen, Inc. | 1.57B | 1.14% | 1,419,124 | 6.31M |
| 129 | OCS | Oculis Holding AG | 1.51B | 0.13% | 295,005 | 992.00K |
| 130 | SVRA | Savara Inc. | 1.48B | 3.02% | 882,232 | - |
| 131 | INVA | Innoviva, Inc. | 1.47B | 0.41% | 237,832 | 388.52M |
| 132 | ATAI | AtaiBeckley Inc. | 1.39B | -0.26% | 2,748,461 | 3.02M |
| 133 | QURE | uniQure N.V. | 1.35B | -3.04% | 1,012,034 | 15.75M |
| 134 | IMTX | Immatics N.V. | 1.34B | 1.01% | 96,928 | 99.45M |
| 135 | TRVI | Trevi Therapeutics, Inc. | 1.32B | -0.96% | 596,289 | - |
| 136 | RLAY | Relay Therapeutics, Inc. | 1.31B | 1.82% | 964,202 | 8.36M |
| 137 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | 1.62% | 1,125,890 | 6.31M |
| 138 | DBVT | DBV Technologies S.A. | 1.28B | 2.30% | 465,972 | 5.50M |
| 139 | ANAB | AnaptysBio, Inc. | 1.27B | -0.52% | 124,688 | 169.47M |
| 140 | ABCL | AbCellera Biologics Inc. | 1.27B | 2.16% | 3,172,536 | 35.33M |
| 141 | RAPP | Rapport Therapeutics, Inc. | 1.26B | 2.04% | 231,506 | - |
| 142 | XERS | Xeris Biopharma Holdings, Inc. | 1.25B | -0.66% | 903,049 | 266.14M |
| 143 | CAPR | Capricor Therapeutics, Inc. | 1.25B | 0.12% | 788,589 | 11.13M |
| 144 | SANA | Sana Biotechnology, Inc. | 1.25B | 2.62% | 1,727,060 | - |
| 145 | EYPT | EyePoint, Inc. | 1.25B | -3.02% | 512,349 | 42.34M |
| 146 | DAWN | Day One Biopharmaceuticals, Inc. | 1.24B | -0.62% | 3,353,957 | 133.67M |
| 147 | PHAR | Pharming Group N.V. | 1.22B | 1.23% | 18,160 | 362.27M |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.19B | 1.78% | 1,741,837 | - |
| 149 | SEPN | Septerna, Inc. | 1.18B | -2.33% | 96,772 | 22.05M |
| 150 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | 3.27% | 745,970 | - |
| 151 | IVA | Inventiva S.A. | 1.15B | 1.40% | 1,327,260 | 19.93M |
| 152 | PVLA | Palvella Therapeutics, Inc. | 1.11B | -4.59% | 190,607 | - |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.09B | 2.85% | 97,481 | 1.40M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.07B | 8.15% | 188,434 | 5.56M |
| 155 | PHAT | Phathom Pharmaceuticals, Inc. | 1.06B | -3.96% | 1,161,605 | 147.19M |
| 156 | ZBIO | Zenas BioPharma, Inc. | 1.05B | -5.94% | 601,310 | 15.00M |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.05B | 3.68% | 1,428,529 | 850.00K |
| 158 | TBPH | Theravance Biopharma, Inc. | 1.02B | -1.47% | 146,377 | 80.33M |
| 159 | SPRY | ARS Pharmaceuticals, Inc. | 1.02B | -1.34% | 1,069,623 | 142.77M |
| 160 | NBTX | Nanobiotix S.A. | 1.01B | -3.53% | 12,623 | 11.93M |
| 161 | VTYX | Ventyx Biosciences, Inc. | 995.17M | -0.07% | 2,544,759 | - |
| 162 | ANNX | Annexon, Inc. | 992.71M | 8.12% | 1,718,804 | - |
| 163 | GHRS | GH Research PLC | 988.75M | 1.21% | 222,573 | - |
| 164 | IOVA | Iovance Biotherapeutics, Inc. | 984.48M | 1.64% | 9,681,662 | 250.43M |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 974.24M | 1.60% | 613,049 | 192.44M |
| 166 | VIR | Vir Biotechnology, Inc. | 960.66M | 15.08% | 2,029,702 | 16.86M |
| 167 | AVBP | ArriVent BioPharma, Inc. | 931.31M | 1.35% | 344,585 | - |
| 168 | BCAX | Bicara Therapeutics Inc. | 921.98M | 0.66% | 342,090 | - |
| 169 | XNCR | Xencor, Inc. | 917.62M | 1.66% | 235,768 | 150.13M |
| 170 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 917.47M | 0.09% | 284,969 | - |
| 171 | URGN | UroGen Pharma Ltd. | 887.03M | -1.97% | 478,444 | 96.52M |
| 172 | CTMX | CytomX Therapeutics, Inc. | 879.37M | -3.35% | 1,765,508 | 113.63M |
| 173 | VALN | Valneva SE | 855.92M | 1.54% | 6,608 | 211.09M |
| 174 | GERN | Geron Corporation | 845.82M | 1.92% | 6,109,912 | 183.40M |
| 175 | YDES | YD Bio Limited | 843.84M | 0.42% | 38,332 | 510.36K |
| 176 | OMER | Omeros Corporation | 843.01M | -3.02% | 1,691,749 | - |
| 177 | DRUG | Bright Minds Biosciences Inc. | 802.55M | 3.40% | 51,673 | - |
| 178 | ARVN | Arvinas, Inc. | 800.23M | 3.57% | 369,498 | 312.30M |
| 179 | JANX | Janux Therapeutics, Inc. | 799.97M | 1.14% | 979,377 | 10.00M |
| 180 | KALV | KalVista Pharmaceuticals, Inc. | 791.05M | 2.22% | 376,286 | 1.43M |
| 181 | MDXG | MiMedx Group, Inc. | 788.64M | -1.21% | 476,731 | 393.44M |
| 182 | SLS | SELLAS Life Sciences Group, Inc. | 786.70M | 6.94% | 7,420,081 | - |
| 183 | ABUS | Arbutus Biopharma Corporation | 783.72M | -3.09% | 763,263 | 14.61M |
| 184 | KURA | Kura Oncology, Inc. | 756.18M | 1.05% | 821,077 | 104.03M |
| 185 | RGNX | REGENXBIO Inc. | 755.80M | 5.89% | 572,379 | 161.32M |
| 186 | GYRE | Gyre Therapeutics, Inc. | 749.85M | 4.04% | 131,253 | 107.27M |
| 187 | NKTR | Nektar Therapeutics | 747.55M | 1.44% | 604,602 | 62.60M |
| 188 | JBIO | Jade Biosciences, Inc. | 739.75M | 5.44% | 231,134 | - |
| 189 | MPLT | MapLight Therapeutics, Inc. | 739.29M | -0.53% | 109,788 | - |
| 190 | NBY | NovaBay Pharmaceuticals, Inc. | 731.49M | -10.69% | 1,375,300 | 10.30M |
| 191 | ATXS | Astria Therapeutics, Inc. | 709.85M | -0.04% | 625,545 | 706.00K |
| 192 | PRME | Prime Medicine, Inc. | 703.73M | 2.19% | 2,316,328 | 5.98M |
| 193 | VOR | Vor Biopharma Inc. | 688.45M | 1.02% | 819,153 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 688.07M | -1.60% | 636,651 | 80.00M |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 678.32M | 2.83% | 177,620 | 282.08M |
| 196 | CGEM | Cullinan Therapeutics, Inc. | 678.20M | 5.61% | 468,113 | - |
| 197 | TENX | Tenax Therapeutics, Inc. | 645.88M | -3.05% | 151,675 | - |
| 198 | PROK | ProKidney Corp. | 640.78M | -0.47% | 1,002,970 | 744.00K |
| 199 | ENGN | enGene Holdings Inc. | 623.96M | 2.36% | 566,519 | - |
| 200 | GOSS | Gossamer Bio, Inc. | 620.30M | 3.08% | 4,232,850 | 44.05M |
| 201 | LENZ | LENZ Therapeutics, Inc. | 620.17M | 2.27% | 973,144 | 17.50M |
| 202 | IVVD | Invivyd, Inc. | 614.73M | -2.68% | 1,898,869 | 50.04M |
| 203 | MGTX | MeiraGTx Holdings plc | 612.54M | 3.96% | 343,984 | 27.42M |
| 204 | EVMN | Evommune, Inc. | 588.40M | 1.44% | 196,747 | 13.00M |
| 205 | KROS | Keros Therapeutics, Inc. | 575.50M | 2.50% | 163,203 | 246.72M |
| 206 | FBRX | Forte Biosciences, Inc. | 568.11M | 4.77% | 90,556 | - |
| 207 | CRMD | CorMedix Inc. | 566.10M | 4.43% | 1,890,261 | 214.30M |
| 208 | LXRX | Lexicon Pharmaceuticals, Inc. | 565.09M | 18.70% | 9,503,772 | 70.86M |
| 209 | REPL | Replimune Group, Inc. | 550.67M | 0.14% | 3,336,402 | - |
| 210 | DSGN | Design Therapeutics, Inc. | 548.33M | 1.86% | 93,196 | - |
| 211 | DRTS | Alpha Tau Medical Ltd. | 548.25M | -0.46% | 182,579 | - |
| 212 | DNA | Ginkgo Bioworks Holdings, Inc. | 545.06M | 6.20% | 521,005 | 180.61M |
| 213 | LBRX | LB Pharmaceuticals Inc | 542.92M | -0.46% | 99,134 | - |
| 214 | ANRO | Alto Neuroscience, Inc. | 534.34M | -1.26% | 56,513 | - |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 532.45M | 3.33% | 969,617 | - |
| 216 | LXEO | Lexeo Therapeutics, Inc. | 525.51M | -0.83% | 850,465 | - |
| 217 | LYEL | Lyell Immunopharma, Inc. | 521.75M | 2.76% | 151,567 | 41.00K |
| 218 | PRTA | Prothena Corporation plc | 516.23M | 3.68% | 363,158 | 11.79M |
| 219 | ZVRA | Zevra Therapeutics, Inc. | 504.99M | -0.55% | 667,416 | 84.39M |
| 220 | NAGE | Niagen Bioscience, Inc. | 492.55M | -0.97% | 381,116 | 124.71M |
| 221 | VSTM | Verastem, Inc. | 490.49M | -4.44% | 819,229 | 13.38M |
| 222 | ALT | Altimmune, Inc. | 486.83M | 5.44% | 2,783,379 | 20.00K |
| 223 | AVXL | Anavex Life Sciences Corp. | 471.76M | 4.97% | 850,352 | - |
| 224 | OCGN | Ocugen, Inc. | 471.60M | -9.58% | 7,696,432 | 5.37M |
| 225 | BCYC | Bicycle Therapeutics plc | 470.31M | 1.65% | 92,179 | 28.34M |
| 226 | SLDB | Solid Biosciences Inc. | 469.02M | 7.12% | 916,445 | - |
| 227 | MNPR | Monopar Therapeutics Inc. | 467.91M | -0.43% | 361,621 | - |
| 228 | ACRS | Aclaris Therapeutics, Inc. | 466.97M | -2.71% | 4,356,098 | 15.74M |
| 229 | VNDA | Vanda Pharmaceuticals Inc. | 460.36M | 1.04% | 581,455 | 212.07M |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 456.87M | 1.66% | 235,008 | - |
| 231 | ABSI | Absci Corporation | 448.11M | 2.76% | 2,119,937 | 2.82M |
| 232 | CTNM | Contineum Therapeutics, Inc. | 447.12M | 3.29% | 76,360 | - |
| 233 | ADCT | ADC Therapeutics SA | 441.00M | 1.14% | 409,747 | 75.21M |
| 234 | NBP | NovaBridge Biosciences | 440.41M | -2.55% | 693,020 | - |
| 235 | FDMT | 4D Molecular Therapeutics, Inc. | 438.80M | 0.79% | 289,407 | 120.00K |
| 236 | PRTC | PureTech Health plc | 423.69M | 2.56% | 970 | 6.39M |
| 237 | VTVT | vTv Therapeutics Inc. | 416.19M | 4.49% | 4,883 | 17.00K |
| 238 | ASMB | Assembly Biosciences, Inc. | 415.83M | -1.90% | 80,269 | 37.19M |
| 239 | DMAC | DiaMedica Therapeutics Inc. | 413.63M | 4.04% | 246,204 | - |
| 240 | IMMP | Immutep Limited | 408.62M | 1.60% | 71,983 | 3.31M |
| 241 | BNTC | Benitec Biopharma Inc. | 406.69M | 3.27% | 61,843 | - |
| 242 | TRDA | Entrada Therapeutics, Inc. | 402.37M | 5.65% | 150,880 | 61.52M |
| 243 | LCTX | Lineage Cell Therapeutics, Inc. | 402.26M | 0.61% | 480,976 | 10.82M |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 399.34M | 1.37% | 1,518,337 | - |
| 245 | AUTL | Autolus Therapeutics plc | 387.24M | 2.46% | 1,120,362 | 51.13M |
| 246 | HELP | Cybin Inc. | 377.77M | -1.43% | 253,500 | - |
| 247 | ZURA | Zura Bio Limited | 374.21M | 14.87% | 3,715,710 | - |
| 248 | PEPG | PepGen Inc. | 372.27M | -8.99% | 513,638 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 362.51M | 0.56% | 134,565 | 65.32M |
| 250 | ALLO | Allogene Therapeutics, Inc. | 358.44M | 1.59% | 3,722,192 | 22.00K |
| 251 | FHTX | Foghorn Therapeutics Inc. | 352.08M | 7.90% | 167,031 | 24.52M |
| 252 | TECX | Tectonic Therapeutic, Inc. | 350.18M | -2.04% | 118,072 | - |
| 253 | AURA | Aura Biosciences, Inc. | 342.92M | 8.65% | 109,998 | - |
| 254 | PBYI | Puma Biotechnology, Inc. | 342.66M | 3.03% | 341,867 | 212.00M |
| 255 | CADL | Candel Therapeutics, Inc. | 342.02M | 5.24% | 570,421 | - |
| 256 | AARD | Aardvark Therapeutics, Inc. | 332.70M | -1.55% | 178,293 | - |
| 257 | XOMA | XOMA Royalty Corporation | 331.74M | 2.60% | 468,186 | 47.11M |
| 258 | ACIU | AC Immune SA | 328.49M | - | 185,274 | 5.48M |
| 259 | NMRA | Neumora Therapeutics, Inc. | 327.98M | 3.21% | 740,219 | - |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 321.77M | 0.27% | 112,435 | 33.98M |
| 261 | TARA | Protara Therapeutics, Inc. | 310.27M | 3.39% | 1,508,404 | - |
| 262 | IMRX | Immuneering Corporation | 307.03M | -0.52% | 1,282,918 | - |
| 263 | ALDX | Aldeyra Therapeutics, Inc. | 305.03M | 6.74% | 715,360 | - |
| 264 | GLSI | Greenwich LifeSciences, Inc. | 303.55M | 2.91% | 441,000 | - |
| 265 | CLLS | Cellectis S.A. | 296.58M | -0.48% | 29,781 | 82.55M |
| 266 | AVTX | Avalo Therapeutics, Inc. | 290.65M | 6.08% | 252,619 | 192.00K |
| 267 | OABI | OmniAb, Inc. | 287.19M | 5.00% | 259,052 | 21.09M |
| 268 | ABEO | Abeona Therapeutics Inc. | 283.15M | -1.60% | 946,868 | 400.00K |
| 269 | ACHV | Achieve Life Sciences, Inc. | 282.67M | -3.28% | 738,873 | - |
| 270 | GUTS | Fractyl Health, Inc. | 281.44M | -3.93% | 3,561,798 | 3.00K |
| 271 | LRMR | Larimar Therapeutics, Inc. | 280.74M | 2.50% | 426,126 | - |
| 272 | NGNE | Neurogene Inc. | 278.92M | 2.78% | 53,898 | 925.00K |
| 273 | STTK | Shattuck Labs, Inc. | 278.43M | 1.38% | 223,500 | 1.00M |
| 274 | RLMD | Relmada Therapeutics, Inc. | 277.93M | -3.81% | 198,755 | - |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 275.98M | 6.59% | 169,165 | - |
| 276 | RZLT | Rezolute, Inc. | 274.01M | 2.25% | 2,143,264 | - |
| 277 | AVIR | Atea Pharmaceuticals, Inc. | 271.49M | 1.02% | 119,080 | - |
| 278 | CBIO | Crescent Biopharma, Inc. | 269.79M | -1.29% | 122,305 | - |
| 279 | SLN | Silence Therapeutics plc | 267.82M | 9.04% | 448,285 | 25.83M |
| 280 | HRTX | Heron Therapeutics, Inc. | 266.79M | 2.46% | 1,143,506 | 155.10M |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 259.91M | 2.98% | 59,193 | 38.79M |
| 282 | PALI | Palisade Bio, Inc. | 257.78M | -8.47% | 4,802,298 | - |
| 283 | IMMX | Immix Biopharma, Inc. | 255.05M | 5.22% | 901,951 | - |
| 284 | MENS | Jyong Biotech Ltd. | 246.08M | -1.84% | 349,135 | - |
| 285 | IKT | Inhibikase Therapeutics, Inc. | 242.11M | 7.27% | 729,401 | 1.00 |
| 286 | ENLV | Enlivex Therapeutics Ltd. | 236.46M | 1.64% | 521,718 | - |
| 287 | CAMP | Camp4 Therapeutics Corporation | 233.98M | 1.58% | 69,963 | 3.80M |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 233.48M | 2.35% | 83,374 | 2.82M |
| 289 | TNXP | Tonix Pharmaceuticals Holding Corp. | 223.67M | 5.93% | 316,557 | 10.30M |
| 290 | ARMP | Armata Pharmaceuticals, Inc. | 223.36M | 3.81% | 26,223 | 5.05M |
| 291 | CABA | Cabaletta Bio, Inc. | 221.41M | 5.02% | 1,739,844 | - |
| 292 | NVCT | Nuvectis Pharma, Inc. | 219.52M | 5.67% | 33,141 | - |
| 293 | MDWD | MediWound Ltd. | 216.68M | -0.59% | 127,088 | 20.93M |
| 294 | TLSA | Tiziana Life Sciences Ltd | 214.13M | 8.23% | 275,137 | - |
| 295 | OVID | Ovid Therapeutics Inc. | 208.29M | 5.26% | 1,146,668 | 6.61M |
| 296 | ALEC | Alector, Inc. | 207.93M | 4.10% | 498,793 | 69.05M |
| 297 | VYGR | Voyager Therapeutics, Inc. | 206.28M | 1.09% | 522,585 | 31.32M |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 205.44M | 1.83% | 227,774 | 97.60M |
| 299 | EDIT | Editas Medicine, Inc. | 204.02M | 3.47% | 1,519,513 | 46.38M |
| 300 | CLYM | Climb Bio, Inc. | 203.63M | -1.27% | 373,137 | - |
| 301 | CCCC | C4 Therapeutics, Inc. | 202.55M | -4.13% | 967,843 | 30.11M |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 202.15M | -1.00% | 2,128,256 | - |
| 303 | SGMT | Sagimet Biosciences Inc. | 202.12M | -1.04% | 177,533 | - |
| 304 | CGEN | Compugen Ltd. | 198.29M | -2.75% | 351,354 | 6.90M |
| 305 | GALT | Galectin Therapeutics Inc. | 197.93M | 2.68% | 305,850 | - |
| 306 | RNAC | Cartesian Therapeutics, Inc. | 195.55M | 4.01% | 72,219 | 1.09M |
| 307 | ZNTL | Zentalis Pharmaceuticals, Inc. | 194.90M | 4.88% | 622,376 | 26.87M |
| 308 | HUMA | Humacyte, Inc. | 192.38M | -2.27% | 8,118,208 | 1.57M |
| 309 | CHRS | Coherus Oncology, Inc. | 192.18M | 2.58% | 576,103 | 277.73M |
| 310 | SABS | SAB Biotherapeutics, Inc. | 191.86M | 0.50% | 527,705 | 114.70K |
| 311 | CRDF | Cardiff Oncology, Inc. | 191.30M | 1.07% | 240,925 | 501.00K |
| 312 | KLRS | Kalaris Therapeutics, Inc. | 184.41M | 0.51% | 14,093 | - |
| 313 | NERV | Minerva Neurosciences, Inc. | 180.45M | -4.58% | 45,219 | - |
| 314 | QNCX | Quince Therapeutics, Inc. | 178.18M | -6.43% | 787,713 | - |
| 315 | IPSC | Century Therapeutics, Inc. | 176.37M | 5.21% | 1,364,611 | 113.34M |
| 316 | SLGL | Sol-Gel Technologies Ltd. | 175.59M | -12.58% | 26,797 | 18.97M |
| 317 | ELDN | Eledon Pharmaceuticals, Inc. | 171.40M | -2.26% | 517,245 | - |
| 318 | PRQR | ProQR Therapeutics N.V. | 169.61M | -4.17% | 323,239 | 18.86M |
| 319 | IPHA | Innate Pharma S.A. | 166.67M | -5.52% | 1,517 | 14.84M |
| 320 | PLX | Protalix BioTherapeutics, Inc. | 164.46M | -0.24% | 755,290 | 61.84M |
| 321 | RANI | Rani Therapeutics Holdings, Inc. | 163.45M | -1.10% | 842,679 | 1.20M |
| 322 | IRD | Opus Genetics, Inc. | 162.76M | 4.42% | 1,539,639 | 14.63M |
| 323 | SRZN | Surrozen, Inc. | 162.09M | 5.17% | 27,875 | 3.60M |
| 324 | NTHI | NeOnc Technologies Holdings, Inc. | 160.27M | -1.56% | 32,039 | 59.99K |
| 325 | VXRT | Vaxart, Inc. | 159.59M | -3.38% | 735,906 | 148.20M |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 158.05M | -0.70% | 72,608 | - |
| 327 | NKTX | Nkarta, Inc. | 154.13M | 6.37% | 899,125 | - |
| 328 | TNYA | Tenaya Therapeutics, Inc. | 153.13M | 0.73% | 1,836,367 | - |
| 329 | CDXS | Codexis, Inc. | 153.10M | 5.28% | 266,635 | 52.93M |
| 330 | PRLD | Prelude Therapeutics Incorporated | 152.44M | 0.54% | 123,296 | 10.50M |
| 331 | MOLN | Molecular Partners AG | 151.55M | -2.10% | 3,239 | 856.30K |
| 332 | BDTX | Black Diamond Therapeutics, Inc. | 145.29M | 6.25% | 979,419 | 70.00M |
| 333 | CNTX | Context Therapeutics Inc. | 144.25M | 1.95% | 1,967,439 | - |
| 334 | CNTB | Connect Biopharma Holdings Limited | 141.44M | 10.00% | 78,479 | 762.00K |
| 335 | UNCY | Unicycive Therapeutics, Inc. | 140.55M | -0.61% | 299,751 | - |
| 336 | ELTX | Elicio Therapeutics, Inc. | 139.63M | 0.50% | 50,064 | - |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 137.72M | -1.70% | 189,464 | 2.00M |
| 338 | CRBU | Caribou Biosciences, Inc. | 137.40M | 5.76% | 1,223,519 | 9.30M |
| 339 | TTRX | Turn Therapeutics Inc. | 137.36M | 0.97% | 34,221 | - |
| 340 | STRO | Sutro Biopharma, Inc. | 134.10M | 5.50% | 231,664 | 105.65M |
| 341 | MCRB | Seres Therapeutics, Inc. | 133.98M | -1.66% | 25,924 | 351.00K |
| 342 | ACTU | Actuate Therapeutics, Inc. | 132.84M | 2.79% | 21,143 | - |
| 343 | SPRO | Spero Therapeutics, Inc. | 132.68M | -1.05% | 123,915 | 40.55M |
| 344 | FATE | Fate Therapeutics, Inc. | 132.08M | 4.09% | 1,162,872 | 7.14M |
| 345 | WHWK | Whitehawk Therapeutics, Inc. | 131.96M | -2.10% | 44,636 | 14.38M |
| 346 | SGMO | Sangamo Therapeutics, Inc. | 127.87M | 3.83% | 3,769,438 | 32.88M |
| 347 | ONCY | Oncolytics Biotech Inc. | 126.44M | 18.61% | 3,554,695 | - |
| 348 | VRCA | Verrica Pharmaceuticals Inc. | 125.84M | -0.88% | 88,599 | 30.83M |
| 349 | CGTX | Cognition Therapeutics, Inc. | 125.79M | 1.79% | 533,508 | - |
| 350 | GNLX | Genelux Corporation | 122.67M | 1.47% | 129,379 | 8.00K |
| 351 | ARTV | Artiva Biotherapeutics, Inc. | 118.55M | 4.55% | 298,736 | 251.00K |
| 352 | ACOG | Alpha Cognition Inc. | 118.28M | -2.51% | 92,412 | 7.43M |
| 353 | KPTI | Karyopharm Therapeutics Inc. | 114.44M | 5.04% | 393,724 | 142.53M |
| 354 | AGEN | Agenus Inc. | 113.59M | -0.89% | 761,634 | 106.83M |
| 355 | RPTX | Repare Therapeutics Inc. | 111.87M | 0.58% | 733,993 | 11.87M |
| 356 | VANI | Vivani Medical, Inc. | 111.62M | 12.50% | 1,486,807 | - |
| 357 | THAR | Tharimmune, Inc. | 111.47M | -3.42% | 431,329 | - |
| 358 | MGNX | MacroGenics, Inc. | 110.70M | - | 330,516 | 127.63M |
| 359 | ABOS | Acumen Pharmaceuticals, Inc. | 109.03M | -3.23% | 123,370 | - |
| 360 | SEER | Seer, Inc. | 105.47M | 0.81% | 76,424 | 16.38M |
| 361 | FBIO | Fortress Biotech, Inc. | 105.22M | -2.59% | 448,618 | 62.30M |
| 362 | ANIX | Anixa Biosciences, Inc. | 104.13M | 0.32% | 107,654 | - |
| 363 | SAVA | Cassava Sciences, Inc. | 103.86M | 8.04% | 1,333,506 | - |
| 364 | INO | Inovio Pharmaceuticals, Inc. | 103.40M | -0.33% | 587,778 | 182.34K |
| 365 | PYXS | Pyxis Oncology, Inc. | 102.11M | -1.20% | 428,039 | 2.82M |
| 366 | EXOZ | eXoZymes, Inc. | 99.96M | 7.59% | 7,033 | -700.00 |
| 367 | BMEA | Biomea Fusion, Inc. | 98.99M | 1.45% | 632,814 | - |
| 368 | CSBR | Champions Oncology, Inc. | 98.80M | 1.64% | 1,154 | 58.42M |
| 369 | ETHZ | ETHZilla Corporation | 95.82M | -0.79% | 398,477 | 4.11M |
| 370 | DTIL | Precision BioSciences, Inc. | 95.56M | -4.80% | 171,186 | 698.00K |
| 371 | COYA | Coya Therapeutics, Inc. | 94.16M | 0.45% | 172,987 | 3.99M |
| 372 | HYFT | MindWalk Holdings Corp. | 92.45M | 1.54% | 296,795 | 19.02M |
| 373 | DWTX | Dogwood Therapeutics, Inc. | 90.95M | 3.47% | 21,345 | - |
| 374 | KRRO | Korro Bio, Inc. | 87.39M | 8.16% | 135,210 | 7.37M |
| 375 | MREO | Mereo BioPharma Group plc | 85.17M | -5.29% | 11,792,565 | 500.00K |
| 376 | MAIA | MAIA Biotechnology, Inc. | 84.18M | - | 1,103,153 | - |
| 377 | ADAG | Adagene Inc. | 82.95M | -5.88% | 9,282 | 103.20K |
| 378 | MNOV | MediciNova, Inc. | 82.81M | 0.30% | 69,082 | 257.92K |
| 379 | SPRB | Spruce Biosciences, Inc. | 81.93M | 7.11% | 27,534 | 697.00K |
| 380 | CBUS | Cibus, Inc. | 81.61M | -11.73% | 390,395 | 3.79M |
| 381 | CALC | CalciMedica, Inc. | 80.98M | 0.36% | 32,880 | - |
| 382 | ACET | Adicet Bio, Inc. | 80.70M | 1.08% | 221,556 | - |
| 383 | IMUX | Immunic, Inc. | 79.08M | 1.97% | 1,045,834 | - |
| 384 | ALXO | ALX Oncology Holdings Inc. | 78.62M | 9.85% | 194,935 | - |
| 385 | ATOS | Atossa Therapeutics, Inc. | 78.50M | 0.78% | 708,399 | - |
| 386 | PLRX | Pliant Therapeutics, Inc. | 78.04M | -0.78% | 882,426 | - |
| 387 | KZIA | Kazia Therapeutics Limited | 77.58M | 1.14% | 84,995 | 1.20M |
| 388 | XBIT | XBiotech Inc. | 76.52M | -0.79% | 32,414 | - |
| 389 | GANX | Gain Therapeutics, Inc. | 76.35M | -0.25% | 879,311 | - |
| 390 | ANVS | Annovis Bio, Inc. | 75.93M | 2.69% | 349,044 | - |
| 391 | PYPD | PolyPid Ltd. | 75.52M | 1.79% | 114,884 | - |
| 392 | OKYO | OKYO Pharma Limited | 75.22M | -6.98% | 233,992 | - |
| 393 | COEP | Coeptis Therapeutics Holdings, Inc. | 74.69M | 6.35% | 23,195 | 501.00K |
| 394 | IMA | ImageneBio, Inc. | 72.90M | 8.64% | 32,646 | 800.00K |
| 395 | ENTX | Entera Bio Ltd. | 72.45M | 0.64% | 123,125 | 124.00K |
| 396 | PTHS | Pelthos Therapeutics Inc. | 71.58M | 3.76% | 5,945 | 7.41M |
| 397 | ATYR | aTyr Pharma, Inc. | 69.18M | -0.07% | 625,916 | 190.00K |
| 398 | BYSI | BeyondSpring Inc. | 69.09M | -1.18% | 17,549 | 1.88M |
| 399 | EQ | Equillium, Inc. | 68.81M | -1.74% | 131,100 | 4.39M |
| 400 | ANL | Adlai Nortye Ltd. | 68.27M | - | 34,980 | -1.35M |
| 401 | IFRX | InflaRx N.V. | 67.75M | 1.12% | 236,941 | 73.73K |
| 402 | NRXP | NRx Pharmaceuticals, Inc. | 65.72M | 1.83% | 319,783 | 242.00K |
| 403 | ACRV | Acrivon Therapeutics, Inc. | 65.63M | 6.12% | 697,308 | - |
| 404 | TCRX | TScan Therapeutics, Inc. | 65.54M | 3.12% | 278,488 | 8.42M |
| 405 | TVGN | Tevogen Bio Holdings Inc. | 65.47M | 2.15% | 108,563 | - |
| 406 | MGX | Metagenomi Therapeutics, Inc. | 61.57M | 1.86% | 188,697 | 30.91M |
| 407 | CRVO | CervoMed Inc. | 60.98M | -5.72% | 116,811 | 6.16M |
| 408 | ATHE | Alterity Therapeutics Limited | 58.84M | -1.56% | 12,695 | 3.57M |
| 409 | ICCC | ImmuCell Corporation | 58.75M | -0.38% | 4,298 | 27.77M |
| 410 | INKT | MiNK Therapeutics, Inc. | 57.97M | 4.48% | 6,723 | - |
| 411 | RADX | Radiopharm Theranostics Limited | 57.36M | -0.40% | 39,256 | 8.20M |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 56.94M | -0.93% | 557,950 | - |
| 413 | GRCE | Grace Therapeutics, Inc. | 56.48M | 2.24% | 66,320 | - |
| 414 | NTRB | Nutriband Inc. | 55.19M | -1.30% | 16,694 | 2.28M |
| 415 | LPCN | Lipocine Inc. | 52.97M | -3.83% | 104,651 | 4.32M |
| 416 | OSTX | OS Therapies Incorporated | 52.47M | -0.67% | 355,680 | - |
| 417 | NRXS | NeurAxis, Inc. | 52.20M | 5.38% | 161,370 | 3.36M |
| 418 | PDSB | PDS Biotechnology Corporation | 51.51M | -0.49% | 690,545 | - |
| 419 | PSTV | Plus Therapeutics, Inc. | 51.16M | 1.40% | 10,867,941 | 5.26M |
| 420 | QTTB | Q32 Bio Inc. | 50.20M | 3.82% | 145,097 | - |
| 421 | IBIO | iBio, Inc. | 50.15M | -0.45% | 1,095,029 | 500.00K |
| 422 | ALGS | Aligos Therapeutics, Inc. | 49.23M | -0.12% | 72,477 | 2.65M |
| 423 | IBO | Impact BioMedical Inc. | 49.22M | 2.55% | 38,391 | 25.00K |
| 424 | LITS | Lite Strategy, Inc. | 48.35M | 0.38% | 851,428 | - |
| 425 | ABVC | ABVC BioPharma, Inc. | 48.32M | -4.65% | 71,695 | 797.92K |
| 426 | TIL | Instil Bio, Inc. | 48.15M | 0.28% | 66,585 | - |
| 427 | GLTO | Galecto, Inc. | 46.79M | 4.89% | 26,565 | - |
| 428 | NXTC | NextCure, Inc. | 45.47M | -2.26% | 2,779 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 45.21M | -1.13% | 87,650 | - |
| 430 | KZR | Kezar Life Sciences, Inc. | 45.18M | 0.33% | 13,570 | - |
| 431 | ANEB | Anebulo Pharmaceuticals, Inc. | 44.78M | - | 57,396 | - |
| 432 | CVM | CEL-SCI Corporation | 44.57M | 0.95% | 20,196 | - |
| 433 | INMB | INmune Bio Inc. | 43.07M | 1.25% | 187,501 | 50.00K |
| 434 | TVRD | Tvardi Therapeutics, Inc. | 43.06M | -0.86% | 36,099 | - |
| 435 | JSPR | Jasper Therapeutics, Inc. | 41.70M | -3.25% | 366,596 | - |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 41.65M | 4.30% | 133,567 | 90.00K |
| 437 | HURA | TuHURA Biosciences, Inc. | 41.60M | 0.63% | 246,710 | - |
| 438 | APLM | Apollomics, Inc. | 41.52M | -3.88% | 26,576 | 6.93M |
| 439 | VERU | Veru Inc. | 41.01M | 0.20% | 128,443 | 16.89M |
| 440 | XCUR | Exicure, Inc. | 40.16M | 2.61% | 30,187 | 500.00K |
| 441 | CING | Cingulate Inc. | 40.09M | -5.42% | 311,241 | - |
| 442 | PASG | Passage Bio, Inc. | 40.07M | -1.29% | 84,786 | - |
| 443 | XLO | Xilio Therapeutics, Inc. | 39.86M | -5.73% | 476,409 | 31.80M |
| 444 | OKUR | OnKure Therapeutics, Inc. | 39.56M | -1.85% | 44,568 | - |
| 445 | ESLA | Estrella Immunopharma, Inc. | 38.25M | -0.11% | 19,470 | - |
| 446 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 38.01M | -3.72% | 2,843,199 | - |
| 447 | LTRN | Lantern Pharma Inc. | 37.80M | -5.85% | 53,703 | - |
| 448 | GBIO | Generation Bio Co. | 37.63M | -0.27% | 114,202 | 15.27M |
| 449 | MRKR | Marker Therapeutics, Inc. | 36.76M | 4.01% | 641,710 | 4.69M |
| 450 | CELU | Celularity Inc. | 36.62M | -3.79% | 4,376 | 40.58M |
| 451 | RNXT | RenovoRx, Inc. | 36.28M | -4.81% | 149,047 | 928.00K |
| 452 | KYNB | Kyntra Bio, Inc. | 35.68M | 3.16% | 18,935 | 8.30M |
| 453 | LSTA | Lisata Therapeutics, Inc. | 35.64M | 87.04% | 4,776,006 | 1.07M |
| 454 | EVAX | Evaxion A/S | 35.20M | -9.83% | 79,539 | 7.65M |
| 455 | CUE | Cue Biopharma, Inc. | 33.98M | 24.59% | 1,995,639 | 7.10M |
| 456 | ANTX | AN2 Therapeutics, Inc. | 33.29M | 2.97% | 45,659 | - |
| 457 | RNTX | Rein Therapeutics Inc. | 33.25M | 5.42% | 115,043 | - |
| 458 | ATRA | Atara Biotherapeutics, Inc. | 32.45M | 4.17% | 330,561 | 151.93M |
| 459 | DYAI | Dyadic International, Inc. | 32.42M | 1.19% | 6,631 | 3.34M |
| 460 | OTLK | Outlook Therapeutics, Inc. | 32.38M | -2.87% | 2,338,870 | 1.41M |
| 461 | SKYE | Skye Bioscience, Inc. | 32.38M | 3.81% | 112,929 | - |
| 462 | BCTX | BriaCell Therapeutics Corp. | 31.78M | -3.20% | 355,973 | - |
| 463 | JUNS | Jupiter Neurosciences, Inc. | 31.16M | 0.56% | 24,545 | - |
| 464 | PLUR | Pluri Inc. | 31.01M | 0.91% | 5,753 | 1.33M |
| 465 | GNTA | Genenta Science S.p.A. | 30.93M | -2.22% | 26,390 | - |
| 466 | SER | Serina Therapeutics, Inc. | 30.13M | -1.56% | 30,779 | 116.00K |
| 467 | PTN | Palatin Technologies, Inc. | 29.89M | 0.27% | 24,954 | 8.85M |
| 468 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.62M | 11.84% | 118,827 | - |
| 469 | BRNS | Barinthus Biotherapeutics plc | 29.40M | - | 50,024 | 14.97M |
| 470 | HOWL | Werewolf Therapeutics, Inc. | 28.64M | 4.54% | 336,537 | 1.14M |
| 471 | SNTI | Senti Biosciences, Inc. | 28.31M | 0.64% | 194,588 | - |
| 472 | RLYB | Rallybio Corporation | 28.30M | 8.93% | 301,078 | 674.00K |
| 473 | NRSN | NeuroSense Therapeutics Ltd. | 27.92M | -7.82% | 1,251,809 | - |
| 474 | BOLD | Boundless Bio, Inc. | 27.76M | 0.81% | 163,300 | - |
| 475 | DARE | Daré Bioscience, Inc. | 27.44M | -2.04% | 97,195 | -57.13K |
| 476 | IGC | IGC Pharma, Inc. | 26.93M | 0.36% | 359,063 | 1.11M |
| 477 | QNTM | Quantum BioPharma Ltd. | 26.21M | -11.36% | 57,080 | - |
| 478 | NNVC | NanoViricides, Inc. | 25.45M | 4.42% | 226,056 | - |
| 479 | PLRZ | Polyrizon Ltd. | 25.10M | 7.95% | 105,128 | - |
| 480 | VTGN | Vistagen Therapeutics, Inc. | 24.93M | -2.15% | 791,825 | 721.00K |
| 481 | LONA | LeonaBio, Inc. | 24.77M | 1.13% | 30,217 | - |
| 482 | HYPD | Hyperion DeFi, Inc. | 24.31M | 0.87% | 172,560 | 345.32K |
| 483 | INTS | Intensity Therapeutics, Inc. | 24.00M | 0.05% | 1,431,768 | - |
| 484 | KLTO | Klotho Neurosciences, Inc. | 23.02M | 0.68% | 406,897 | - |
| 485 | FBLG | FibroBiologics, Inc. | 22.33M | 4.09% | 207,826 | - |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 21.70M | 0.12% | 39,708 | 15.65M |
| 487 | KTTA | Pasithea Therapeutics Corp. | 20.78M | -2.95% | 108,335 | - |
| 488 | CASI | CASI Pharmaceuticals, Inc. | 20.11M | -1.15% | 15,475 | 26.85M |
| 489 | ALLR | Allarity Therapeutics, Inc. | 20.06M | -0.43% | 43,443 | - |
| 490 | TRAW | Traws Pharma, Inc. | 20.00M | -2.99% | 203,262 | 2.85M |
| 491 | LNAI | Lunai Bioworks Inc. | 19.68M | -3.04% | 91,865 | - |
| 492 | BCAB | BioAtla, Inc. | 19.15M | -5.90% | 1,916,930 | 11.00M |
| 493 | VYNE | VYNE Therapeutics Inc. | 19.02M | -0.42% | 289,455 | 524.00K |
| 494 | LIMN | Liminatus Pharma, Inc. | 18.97M | -3.97% | 29,925 | - |
| 495 | LEXX | Lexaria Bioscience Corp. | 18.67M | 1.94% | 114,462 | 522.00K |
| 496 | KAPA | Kairos Pharma, Ltd. | 18.03M | -1.01% | 66,345 | - |
| 497 | CLGN | CollPlant Biotechnologies Ltd. | 18.01M | -4.08% | 15,466 | 2.48M |
| 498 | OSRH | OSR Holdings, Inc. | 17.89M | -3.05% | 967,970 | -90.52K |
| 499 | PMN | ProMIS Neurosciences, Inc. | 17.59M | 0.07% | 3,354 | - |
| 500 | KALA | KALA BIO, Inc. | 17.22M | 1.15% | 624,929 | - |
| 501 | CVKD | Cadrenal Therapeutics, Inc. | 16.95M | -1.62% | 39,364 | - |
| 502 | ITRM | Iterum Therapeutics plc | 16.72M | -3.92% | 298,067 | 390.00K |
| 503 | CTXR | Citius Pharmaceuticals, Inc. | 16.20M | -3.80% | 245,694 | - |
| 504 | AEON | AEON Biopharma, Inc. | 16.10M | 13.33% | 291,607 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 15.67M | -5.61% | 4,385,087 | - |
| 506 | CLRB | Cellectar Biosciences, Inc. | 15.60M | 5.14% | 37,258 | - |
| 507 | APLT | Applied Therapeutics, Inc. | 15.43M | 1.20% | 4,238,775 | 1.00M |
| 508 | IOBT | IO Biotech, Inc. | 15.15M | -59.17% | 17,141,458 | - |
| 509 | COCP | Cocrystal Pharma, Inc. | 14.54M | 0.48% | 60,074 | - |
| 510 | MBRX | Moleculin Biotech, Inc. | 14.53M | 10.80% | 191,166 | - |
| 511 | SNGX | Soligenix, Inc. | 13.97M | 0.36% | 141,776 | 2.34K |
| 512 | BCDA | BioCardia, Inc. | 13.69M | -0.77% | 57,698 | 3.00K |
| 513 | NCNA | NuCana plc | 13.32M | -0.31% | 49,582 | - |
| 514 | TPST | Tempest Therapeutics, Inc. | 12.91M | 1.55% | 13,703 | - |
| 515 | BLRX | BioLineRx Ltd. | 12.42M | 1.63% | 7,979 | 12.74M |
| 516 | GDTC | CytoMed Therapeutics Limited | 12.12M | 0.01% | 7,557 | 573.19K |
| 517 | EDSA | Edesa Biotech, Inc. | 12.00M | -1.37% | 72,355 | - |
| 518 | BOLT | Bolt Biotherapeutics, Inc. | 12.00M | 0.17% | 12,823 | 5.20M |
| 519 | IMNN | Imunon, Inc. | 11.90M | 1.16% | 21,960 | - |
| 520 | SNSE | Sensei Biotherapeutics, Inc. | 11.88M | -1.98% | 16,162 | - |
| 521 | AKTX | Akari Therapeutics, Plc | 11.88M | -1.67% | 202,237 | - |
| 522 | CRIS | Curis, Inc. | 11.70M | -6.51% | 257,264 | 11.65M |
| 523 | LGVN | Longeveron Inc. | 11.43M | 0.92% | 55,834 | 1.44M |
| 524 | PHIO | Phio Pharmaceuticals Corp. | 11.30M | -2.78% | 345,762 | - |
| 525 | NCEL | NewcelX Ltd. | 11.03M | -2.42% | 46,364 | - |
| 526 | GRDX | GridAI Technologies Corp. | 10.99M | -0.30% | 82,271 | - |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 10.46M | 7.59% | 47,529 | - |
| 528 | BRTX | BioRestorative Therapies, Inc. | 10.30M | 3.57% | 2,640 | 383.40K |
| 529 | INAB | IN8bio, Inc. | 10.00M | 0.42% | 50,924 | - |
| 530 | PULM | Pulmatrix, Inc. | 9.68M | -0.75% | 23,593 | 3.00K |
| 531 | MTVA | MetaVia Inc. | 9.27M | -3.67% | 428,390 | - |
| 532 | ERNA | Ernexa Therapeutics Inc. | 9.26M | -3.28% | 88,418 | 1,000.00 |
| 533 | BIVI | BioVie Inc. | 9.20M | - | 88,151 | - |
| 534 | ALZN | Alzamend Neuro, Inc. | 9.16M | -0.41% | 59,160 | - |
| 535 | APVO | Aptevo Therapeutics Inc. | 9.15M | -6.68% | 83,325 | - |
| 536 | PMCB | PharmaCyte Biotech, Inc. | 8.82M | 1.71% | 136,182 | - |
| 537 | EVGN | Evogene Ltd. | 8.77M | 2.53% | 10,032 | 8.02M |
| 538 | IMRN | Immuron Limited | 8.56M | 0.32% | 21,196 | 4.78M |
| 539 | XTLB | XTL Biopharmaceuticals Ltd. | 8.40M | -0.58% | 119,532 | 968.00K |
| 540 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.39M | -4.31% | 30,469 | - |
| 541 | RNAZ | TransCode Therapeutics, Inc. | 8.28M | 3.32% | 5,924 | - |
| 542 | ABP | Abpro Holdings, Inc. | 8.28M | -1.40% | 7,381 | 183.00K |
| 543 | ICU | SeaStar Medical Holding Corporation | 8.18M | -0.41% | 47,792 | 881.00K |
| 544 | KPRX | Kiora Pharmaceuticals, Inc. | 8.02M | -1.04% | 6,775 | 20.00K |
| 545 | APM | Aptorum Group Limited | 7.98M | -3.92% | 30,165 | - |
| 546 | ADXN | Addex Therapeutics Ltd | 7.79M | 0.85% | 2,799 | 198.82K |
| 547 | CLDI | Calidi Biotherapeutics, Inc. | 7.46M | 0.99% | 45,364 | - |
| 548 | MBIO | Mustang Bio, Inc. | 7.41M | -1.46% | 42,532 | - |
| 549 | GTBP | GT Biopharma, Inc. | 7.40M | -4.05% | 759,309 | - |
| 550 | SYBX | Synlogic, Inc. | 7.25M | 10.70% | 305,048 | 8.00K |
| 551 | PCSA | Processa Pharmaceuticals, Inc. | 7.05M | -4.01% | 33,950 | - |
| 552 | BGMS | Bio Green Med Solution, Inc. | 7.01M | -2.26% | 15,468 | 81.00K |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 6.81M | -1.52% | 118,321 | 6.00K |
| 554 | TOVX | Theriva Biologics, Inc. | 6.79M | 5.14% | 1,296,089 | - |
| 555 | SLXN | Silexion Therapeutics Corp | 6.75M | -3.57% | 23,432 | - |
| 556 | GNPX | Genprex, Inc. | 6.54M | - | 630,450 | - |
| 557 | TCRT | Alaunos Therapeutics, Inc. | 6.47M | -0.34% | 15,496 | 6.00K |
| 558 | PPBT | Purple Biotech Ltd | 6.47M | -3.01% | 62,796 | - |
| 559 | ADIL | Adial Pharmaceuticals, Inc. | 6.03M | 0.42% | 148,546 | - |
| 560 | ACXP | Acurx Pharmaceuticals, Inc. | 5.97M | -0.36% | 34,545 | - |
| 561 | APRE | Aprea Therapeutics, Inc. | 5.82M | -4.97% | 92,823 | 488.24K |
| 562 | INDP | Indaptus Therapeutics, Inc. | 5.70M | -9.00% | 94,567 | - |
| 563 | XBIO | Xenetic Biosciences, Inc. | 5.68M | -0.80% | 25,771 | 2.86M |
| 564 | CANF | Can-Fite BioPharma Ltd. | 5.36M | - | 39,306 | 560.00K |
| 565 | GOVX | GeoVax Labs, Inc. | 5.31M | 10.75% | 117,823 | 3.35M |
| 566 | ASBP | Aspire Biopharma Holdings, Inc. | 5.24M | -2.99% | 213,095 | 1.94K |
| 567 | VIVS | VivoSim Labs, Inc. | 5.20M | -3.16% | 11,450 | 140.00K |
| 568 | CYCN | Cyclerion Therapeutics, Inc. | 5.18M | 0.74% | 46,566 | 2.86M |
| 569 | SILO | Silo Pharma, Inc. | 4.70M | -2.35% | 41,546 | 72.10K |
| 570 | REVB | Revelation Biosciences, Inc. | 4.67M | -15.57% | 5,304,185 | - |
| 571 | PHGE | BiomX Inc. | 4.63M | 10.18% | 52,539 | - |
| 572 | DCOY | Decoy Therapeutics Inc. | 4.55M | -12.61% | 404,939 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.42M | 0.75% | 19,008 | - |
| 574 | CNSP | CNS Pharmaceuticals, Inc. | 4.34M | -3.85% | 30,333 | - |
| 575 | ENVB | Enveric Biosciences, Inc. | 4.17M | 0.87% | 33,267 | - |
| 576 | OGEN | Oragenics, Inc. | 4.13M | 2.06% | 123,104 | - |
| 577 | LYRA | Lyra Therapeutics, Inc. | 4.10M | -1.28% | 40,947 | 600.00K |
| 578 | ELAB | PMGC Holdings Inc. | 4.03M | 4.94% | 111,044 | 285.95K |
| 579 | XRTX | XORTX Therapeutics Inc. | 4.02M | 2.14% | 15,589 | - |
| 580 | MTNB | Matinas BioPharma Holdings, Inc. | 3.97M | -2.89% | 67,742 | - |
| 581 | CMND | Clearmind Medicine Inc. | 3.96M | - | 30,158 | - |
| 582 | JAGX | Jaguar Health, Inc. | 3.54M | -8.77% | 1,934,054 | 11.79M |
| 583 | SPRC | SciSparc Ltd. | 3.49M | -3.64% | 143,342 | 1.31M |
| 584 | PPCB | Propanc Biopharma, Inc. | 3.47M | -12.99% | 517,237 | - |
| 585 | ARTL | Artelo Biosciences, Inc. | 3.47M | 3.61% | 53,840 | - |
| 586 | HCWB | HCW Biologics Inc. | 3.47M | -4.81% | 45,178 | 422.03K |
| 587 | ENSC | Ensysce Biosciences, Inc. | 3.38M | -0.96% | 75,873 | 4.49M |
| 588 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.27M | 2.31% | 110,548 | 15.78K |
| 589 | BBLG | Bone Biologics Corporation | 3.08M | -0.87% | 28,180 | - |
| 590 | AZTR | Azitra, Inc. | 3.04M | -5.48% | 644,347 | 7.50K |
| 591 | GRI | GRI Bio, Inc. | 3.03M | -6.55% | 1,226,741 | - |
| 592 | SCNI | Scinai Immunotherapeutics Ltd. | 2.94M | -2.00% | 7,662 | 1.15M |
| 593 | ADTX | Aditxt, Inc. | 2.68M | 27.97% | 24,406,442 | 5.95K |
| 594 | ONCO | Onconetix, Inc. | 2.64M | -2.86% | 24,420 | 1.22M |
| 595 | CDT | CDT Equity Inc. | 2.47M | -3.14% | 145,723 | - |
| 596 | DRMA | Dermata Therapeutics, Inc. | 2.47M | -3.23% | 164,292 | - |
| 597 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.06M | -3.23% | 481,382 | 1.36M |
| 598 | VRAX | Virax Biolabs Group Limited | 2.02M | -5.07% | 381,895 | 2.99K |
| 599 | BDRX | Biodexa Pharmaceuticals Plc | 1.79M | -3.62% | 117,110 | 104.90K |
| 600 | MLEC | Moolec Science SA | 1.67M | 42.14% | 5,552,924 | 7.83M |
| 601 | PBM | Psyence Biomedical Ltd. | 862.31K | -79.85% | 2,184,568 | - |